308 related articles for article (PubMed ID: 25257725)
1. Neoadjuvant chemotherapy for resectable colorectal liver metastases: what is the evidence? Results of a systematic review of comparative studies.
Nigri G; Petrucciani N; Ferla F; La Torre M; Aurello P; Ramacciato G
Surgeon; 2015 Apr; 13(2):83-90. PubMed ID: 25257725
[TBL] [Abstract][Full Text] [Related]
2. Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases?
Lubezky N; Geva R; Shmueli E; Nakache R; Klausner JM; Figer A; Ben-Haim M
World J Surg; 2009 May; 33(5):1028-34. PubMed ID: 19234865
[TBL] [Abstract][Full Text] [Related]
3. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
Reddy SK; Tsung A; Marsh JW; Geller DA
J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
[TBL] [Abstract][Full Text] [Related]
4. [Resectable colorectal liver metastases: pro neoadjuvant therapy - contra neoadjuvant therapy].
Arnold D; Stöltzing O; Timm S; Stein A; Geissler M; Lang H
Z Gastroenterol; 2010 Dec; 48(12):1375-83. PubMed ID: 21125514
[TBL] [Abstract][Full Text] [Related]
5. Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.
Ayez N; van der Stok EP; de Wilt H; Radema SA; van Hillegersberg R; Roumen RM; Vreugdenhil G; Tanis PJ; Punt CJ; Dejong CH; Jansen RL; Verheul HM; de Jong KP; Hospers GA; Klaase JM; Legdeur MC; van Meerten E; Eskens FA; van der Meer N; van der Holt B; Verhoef C; Grünhagen DJ
BMC Cancer; 2015 Mar; 15():180. PubMed ID: 25884448
[TBL] [Abstract][Full Text] [Related]
6. Use of Neoadjuvant Chemotherapy Plus Molecular Targeted Therapy in Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
Sabanathan D; Eslick GD; Shannon J
Clin Colorectal Cancer; 2016 Dec; 15(4):e141-e147. PubMed ID: 27174607
[TBL] [Abstract][Full Text] [Related]
7. Topics related to neoadjuvant chemotherapy for resectable liver metastases from colorectal cancer.
Ke S; Zhan S; Zhu H; Yan D
J BUON; 2018; 23(2):296-301. PubMed ID: 29745068
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases.
Ercolani G; Cucchetti A; Cescon M; Peri E; Brandi G; Del Gaudio M; Ravaioli M; Zanello M; Pinna AD
Eur J Cancer; 2011 Oct; 47(15):2291-8. PubMed ID: 21652204
[TBL] [Abstract][Full Text] [Related]
9. Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.
Ichida H; Mise Y; Ito H; Ishizawa T; Inoue Y; Takahashi Y; Shinozaki E; Yamaguchi K; Saiura A
World J Surg Oncol; 2019 Jun; 17(1):100. PubMed ID: 31196104
[TBL] [Abstract][Full Text] [Related]
10. [Hepatectomy for colorectal liver metastases after neoadjuvant chemotherapy].
Brouquet A; Benoist S
Bull Cancer; 2011 Jan; 98(1):11-8. PubMed ID: 21300602
[TBL] [Abstract][Full Text] [Related]
11. Resectable colorectal liver metastases: optimal sequencing of chemotherapy.
Chua TC; Morris DL
J Gastrointest Cancer; 2012 Sep; 43(3):496-8. PubMed ID: 21365476
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases.
Brouquet A; Nordlinger B
Scand J Gastroenterol; 2012 Mar; 47(3):286-95. PubMed ID: 22182353
[TBL] [Abstract][Full Text] [Related]
13. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?
Ihnát P; Vávra P; Zonča P
World J Gastroenterol; 2015 Jun; 21(22):7014-21. PubMed ID: 26078580
[TBL] [Abstract][Full Text] [Related]
14. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies.
Lorenz M; Staib-Sebler E; Gog C; Proschek D; Jauch KW; Ridwelski K; Hohenberger W; Gassel HJ; Lehmann U; Vestweber KH; Padberg W; Zamzow K; Müller HH
Zentralbl Chir; 2003 Feb; 128(2):87-94. PubMed ID: 12632273
[TBL] [Abstract][Full Text] [Related]
15. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
Benoist S; Nordlinger B
Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
[TBL] [Abstract][Full Text] [Related]
16. Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases.
Chua TC; Saxena A; Liauw W; Kokandi A; Morris DL
Ann Surg Oncol; 2010 Feb; 17(2):492-501. PubMed ID: 19856028
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant therapy of colorectal liver metastases: lessons learned from clinical trials.
Brouquet A; Nordlinger B
J Surg Oncol; 2010 Dec; 102(8):932-6. PubMed ID: 21165995
[TBL] [Abstract][Full Text] [Related]
18. [HEMIHEPATECTOMY FOR RESECTABLE HEPATIC METASTASIS FROM COLORECTAL CANCER WITH POOR PROGNOSIS].
Patyutko YI; Kotelnikov AG; Mamontov KG; Podluzhny DV; Ponomarenko AA
Vopr Onkol; 2015; 61(3):439-47. PubMed ID: 26242159
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy before liver resection of colorectal metastases: friend or foe?
Lehmann K; Rickenbacher A; Weber A; Pestalozzi BC; Clavien PA
Ann Surg; 2012 Feb; 255(2):237-47. PubMed ID: 22041509
[TBL] [Abstract][Full Text] [Related]
20. Preoperative chemotherapy and the outcome of liver resection for colorectal metastases.
Hewes JC; Dighe S; Morris RW; Hutchins RR; Bhattacharya S; Davidson BR
World J Surg; 2007 Feb; 31(2):353-64; discussion 365-6. PubMed ID: 17219289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]